Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K

被引:20
作者
Wang, Yali [1 ,2 ]
Xue, Situ [1 ,2 ]
Li, Ruolan [3 ]
Zheng, Zhihui [3 ]
Yi, Hong [1 ,2 ]
Li, Zhuorong [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
[3] North China Pharmaceutical Grp Corp, New Drug Res & Dev Ctr, Shijiazhuang 050015, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
Anti-tumor activity; Chalcone; Cat L; Cat K; CATHEPSIN-K; CYSTEINE CATHEPSINS; SELECTIVE INHIBITORS; BREAST-CANCER; EXPRESSION; TUMOR; PROGRESSION; CARCINOMA; INVASION; PROTEASE;
D O I
10.1016/j.bmc.2017.09.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of chalcone derivatives bearing benzamide or benzenesulfonamide moieties were synthesized and evaluated for their anti-tumor effect on HCT116, MCF7 and 143B cell lines in vitro. SAR analysis showed that compounds bearing a benzenesulfonamide group had greater potency than those bearing a benzamide group. It was also shown that compounds with a mono-methyl or mono-halogen group at the 3-position on the terminal phenyl ring were more effective than those with trifluoromethyl or methoxy groups. Compound 8e exhibited the most potent anti-tumor activities against HCT116, MCF7 and 143B cell lines, with IC50 values of 0.597, 0.886 and 0.791 mu M, respectively. Molecular docking studies and enzymatic assays demonstrated that the anti-tumor activity of compound 8e might be regulated by Cat L and Cat K. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8 / 16
页数:9
相关论文
共 43 条
  • [1] Insights from molecular modeling into the selective inhibition of cathepsin S by its inhibitor
    Ahmad, Sabahuddin
    Siddiqi, Mohammad Imran
    [J]. JOURNAL OF MOLECULAR MODELING, 2017, 23 (03)
  • [2] BROMME D, 1989, BIOCHEM J, V264, P475
  • [3] Cai X, [No title captured], Patent No. [US 20140018368A1, 20140018368]
  • [4] Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients
    Chen, Qingyong
    Fei, Jun
    Wu, Lijun
    Jiang, Zhongyong
    Wu, Yuquan
    Zheng, Yun
    Lu, Guohua
    [J]. ONCOLOGY LETTERS, 2011, 2 (04) : 693 - 699
  • [5] Cysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications
    Cheng, Xian Wu
    Huang, Zhe
    Kuzuya, Masafumi
    Okumura, Kenji
    Murohara, Toyoaki
    [J]. HYPERTENSION, 2011, 58 (06) : 978 - 986
  • [6] Asymmetric synthesis and evaluation of epoxy-α-acyloxycarboxamides as selective inhibitors of cathepsin L
    dos Santos, Deborah A.
    Deobald, Anna Maria
    Cornelio, Vivian E.
    Avila, Roberta M. D.
    Cornea, Renata C.
    Bernasconi, Gilberto C. R.
    Paixao, Marcio W.
    Vieira, Paulo C.
    Correa, Arlene G.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (17) : 4620 - 4627
  • [7] Fröhlich E, 2001, CANCER-AM CANCER SOC, V91, P972
  • [8] Inhibitory potential of some chalcones on cathepsins B, H and L
    Garg, Shweta
    Raghav, Neera
    [J]. RSC ADVANCES, 2015, 5 (89): : 72937 - 72949
  • [9] The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
    Gauthier, Jacques Yves
    Chauret, Nathalie
    Cromlish, Wanda
    Desmarais, Sylvie
    Duong, Le T.
    Falgueyret, Jean-Pierre
    Kimmel, Donald B.
    Lamontagne, Sonia
    Leger, Serge
    LeRiche, Tammy
    Li, Chun Sing
    Masse, Frederic
    Mckay, Daniel J.
    Nicoll-Griffith, Deborah A.
    Oballa, Renata A.
    Palmer, James T.
    Percival, M. David
    Riendeau, Denis
    Robichaud, Joel
    Rodan, Gideon A.
    Rodan, Sevgi B.
    Seto, Carmai
    Therien, Michel
    Truong, Vouy-Linh
    Venuti, Michael C.
    Wesolowski, Gregg
    Young, Robert N.
    Zamboni, Robert
    Black, W. Cameron
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 923 - 928
  • [10] Cysteine Cathepsins and the cutting edge of cancer invasion
    Gocheva, Vasilena
    Joyce, Johanna A.
    [J]. CELL CYCLE, 2007, 6 (01) : 60 - 64